Pharmafile Logo

neurorecovery

Train your Brain for Success

Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. We also delve into Brain...

Impetus Digital

Impetus Digital Fireside Chat With Richie Bavasso From NqMedical

Richie Bavasso, founder and CEO of nQMedical, discusses everything from digital therapeutics, diagnostics, and other data-driven solutions for neurodegenerative diseases to Richie’s favorite media outlets, his work at nQMedical, and lessons learned...

Impetus Digital

- PMLiVE

Policy and public health: ML and AI in healthcare

What are the hurdles for machine learning and artificial intelligence in pharma?

- PMLiVE

Researchers discover new antibiotic using AI

First antibiotic to be discovered using this method

- PMLiVE

Google’s DeepMind AI outperforms doctors on breast cancer screening

System reduced false positive and false negative decisions

AI: opportunities and barriers to improving healthcare

How AI is shaping the future of healthcare

- PMLiVE

Combining hard technology with human skills

Chris Ross explores why pharma’s multichannel maturity isn’t just about hard technology – success depends on ‘human’ enablers

- PMLiVE

Amgen exits neuroscience R&D to focus on growth areas

Move has resulted in loss of around 180 jobs

- PMLiVE

Eli Lilly shutters UK neuroscience unit, with 80 job losses expected

Company says decision is not related to Brexit

Diagnosing the lag in neuropsychiatric treatments

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop...

Blue Latitude Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links